PATENT CLAIM ANALYSIS

Application Number: 16046304
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["546", "234000"]

Abstract:
This invention relates to generally inhibiting histone deacetylase (“HDAC”) enzymes (e.g., HDAC1, HDAC2, and HDAC3).

Claim (Index 12):
The compound or salt of  claim 1 , having a structure:

Metadata:
- Claim Count in Document: 1.0
- Percentile: 95.0
- Lexical Diversity: 1.19048
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14598583', '15337354', '13843261', '16046382', '15860741']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8133186876540327
- 35 USC 102 Novelty (BERT): 0.512538420056009
- Combined Prediction Score: 0.7832406608942304
- Mean Citation Score: 325.265282
- Max Citation Score: 328.54785
- Similarity Product: 322.09813748267584

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test